Your browser doesn't support javascript.
loading
Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's Disease.
Hopfner, Franziska; Mueller, Stefanie H; Szymczak, Silke; Junge, Olaf; Tittmann, Lukas; May, Sandra; Lohmann, Katja; Grallert, Harald; Lieb, Wolfgang; Strauch, Konstantin; Müller-Nurasyid, Martina; Berger, Klaus; Schormair, Barbara; Winkelmann, Juliane; Mollenhauer, Brit; Trenkwalder, Claudia; Maetzler, Walter; Berg, Daniela; Kasten, Meike; Klein, Christine; Höglinger, Günter U; Gasser, Thomas; Deuschl, Günther; Franke, André; Krawczak, Michael; Dempfle, Astrid; Kuhlenbäumer, Gregor.
Afiliação
  • Hopfner F; Department of Neurology, Universitätsklinikum Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
  • Mueller SH; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Szymczak S; Department of Neurology, Universitätsklinikum Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
  • Junge O; Institute of Health Informatics, University College London, London, United Kingdom.
  • Tittmann L; Institute of Medical Informatics and Statistics, Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany.
  • May S; Institute of Medical Informatics and Statistics, Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Lohmann K; Institute of Epidemiology, University of Kiel, Kiel, Germany.
  • Grallert H; Institute of Clinical Molecular Biology, Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Lieb W; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Strauch K; Institute of Epidemiology II, German Research Center for Environmental Health, Helmholtz Zentrum München, Neuherberg, Germany.
  • Müller-Nurasyid M; Research Unit of Molecular Epidemiology, German Research Center for Environmental Health, Helmholtz Zentrum München, Neuherberg, Germany.
  • Berger K; German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
  • Schormair B; Institute of Epidemiology, University of Kiel, Kiel, Germany.
  • Winkelmann J; Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
  • Mollenhauer B; Institute of Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-University, Munich, Germany.
  • Trenkwalder C; Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
  • Maetzler W; Department of Medicine I, Ludwig-Maximilians-Universität, Munich, Germany.
  • Berg D; DZHK (German Centre for Cardiovascular Research), Munich Heart Alliance, Munich, Germany.
  • Kasten M; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
  • Klein C; Institute of Neurogenomics, Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Neuherberg, Germany.
  • Höglinger GU; Institute of Neurogenomics, Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Neuherberg, Germany.
  • Gasser T; Institute of Human Genetics, Faculty of Medicine, Technical University Munich, Munich, Germany.
  • Deuschl G; Munich Cluster for Systems Neurology (SyNergy), München, Deutschland.
  • Franke A; Paracelsus-Elena-Klinik Kassel, Kassel, Germany.
  • Krawczak M; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
  • Dempfle A; Clinic for Neurosurgery, University Medical Centre, Georg August University Göttingen, Göttingen, Germany.
  • Kuhlenbäumer G; Paracelsus-Elena Hospital, Kassel, Germany.
Mov Disord ; 35(7): 1245-1248, 2020 07.
Article em En | MEDLINE | ID: mdl-32267580
OBJECTIVE: Impaired lysosomal degradation of α-synuclein and other cellular constituents may play an important role in Parkinson's disease (PD). Rare genetic variants in the glucocerebrosidase (GBA) gene were consistently associated with PD. Here we examine the association between rare variants in lysosomal candidate genes and PD. METHODS: We investigated the association between PD and rare genetic variants in 23 lysosomal candidate genes in 4096 patients with PD and an equal number of controls using pooled targeted next-generation DNA sequencing. Genewise association of rare variants in cases or controls was analyzed using the optimized sequence kernel association test with Bonferroni correction for the 23 tested genes. RESULTS: We confirm the association of rare variants in GBA with PD and report novel associations for rare variants in ATP13A2, LAMP1, TMEM175, and VPS13C. CONCLUSION: Rare variants in selected lysosomal genes, first and foremost GBA, are associated with PD. Rare variants in ATP13A2 and VPC13C previously linked to monogenic PD and more common variants in TMEM175 and VPS13C previously linked to sporadic PD in genome-wide association studies are associated with PD. © 2020 International Parkinson and Movement Disorder Society.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos